Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L T Cooper

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cancer Research|September 15, 1995
Expression of the p16 and p15 cyclin-dependent kinase inhibitors in lymphocyte activation and neuronal differentiationA F Lois, L T Cooper, Y Geng, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|November 7, 2000
Giant cell myocarditis as a manifestation of drug hypersensitivityP R Daniels, G J Berry, H D Tazelaar, et al.
Clinical and Experimental Rheumatology|January 29, 2005
Predictors of left ventricular dysfunction in patients with Takayasu's or giant cell aortitisD H Pfizenmaier, F O Al Atawi, Y Castillo, et al.
Lupus|August 16, 2012
A contemporary case series of lupus myocarditisG M Zawadowski, K W Klarich, K G Moder, et al.
International Journal of Dermatology|December 12, 2001
Cutaneous and gastrointestinal tract hemangiomas associated with disappearing bones: Gorham syndromeT S Hsu, L T Cooper, T P Maus, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|October 4, 2000
Survival outcomes of patients with giant cell myocarditis bridged by ventricular assist devicesE S Brilakis, L J Olson, G J Berry, et al.
Mayo Clinic Proceedings|December 11, 1999
Combined immunosuppression for the treatment of idiopathic giant cell myocarditisV V Menghini, V Savcenko, L J Olson, et al.
Vascular Medicine (London, England)|April 18, 2002
Proteinuria in a placebo-controlled study of basic fibroblast growth factor for intermittent claudicationL T Cooper, W R Hiatt, M A Creager, et al.
Journal of Cardiovascular Translational Research|May 6, 2020
A Prospective Pilot Study to Identify a Myocarditis Cohort who may Safely Resume Sports Activities 3 Months after DiagnosisD Patriki, N Baltensperger, J Berg, et al.
Leukemia|December 7, 2016
EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemiaS Charmsaz, F Al-Ejeh, T M Yeadon, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancer Research|September 15, 1995
Expression of the p16 and p15 cyclin-dependent kinase inhibitors in lymphocyte activation and neuronal differentiationA F Lois, L T Cooper, Y Geng, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|November 7, 2000
Giant cell myocarditis as a manifestation of drug hypersensitivityP R Daniels, G J Berry, H D Tazelaar, et al.
Clinical and Experimental Rheumatology|January 29, 2005
Predictors of left ventricular dysfunction in patients with Takayasu's or giant cell aortitisD H Pfizenmaier, F O Al Atawi, Y Castillo, et al.
Lupus|August 16, 2012
A contemporary case series of lupus myocarditisG M Zawadowski, K W Klarich, K G Moder, et al.
International Journal of Dermatology|December 12, 2001
Cutaneous and gastrointestinal tract hemangiomas associated with disappearing bones: Gorham syndromeT S Hsu, L T Cooper, T P Maus, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|October 4, 2000
Survival outcomes of patients with giant cell myocarditis bridged by ventricular assist devicesE S Brilakis, L J Olson, G J Berry, et al.
Mayo Clinic Proceedings|December 11, 1999
Combined immunosuppression for the treatment of idiopathic giant cell myocarditisV V Menghini, V Savcenko, L J Olson, et al.
Vascular Medicine (London, England)|April 18, 2002
Proteinuria in a placebo-controlled study of basic fibroblast growth factor for intermittent claudicationL T Cooper, W R Hiatt, M A Creager, et al.
Journal of Cardiovascular Translational Research|May 6, 2020
A Prospective Pilot Study to Identify a Myocarditis Cohort who may Safely Resume Sports Activities 3 Months after DiagnosisD Patriki, N Baltensperger, J Berg, et al.
Leukemia|December 7, 2016
EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemiaS Charmsaz, F Al-Ejeh, T M Yeadon, et al.
Pageof 3